Independent provider comparison
Updated September 21, 2026
MEDVi vs Ro: Which GLP-1 provider is better?
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
The decision
Which should you choose, MEDVi or Ro?
Short answer: Ro scores higher on our published rubric, 7.2/10 against 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Ro is $149/mo membership + medication.
Consider MEDVi if
Users who want both oral and injectable compounded options in one telehealth program.
Consider Ro if
Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing.
Scores follow our published methodology. Partnership status does not change the score or the factual comparison.
Cost
First charge, renewal and commitment
Treatment
Medication, form and approval status
Care
Clinical review and ongoing support
Terms
Cancellation and material cautions
MEDVi
#25 of 36Best for users who want both oral and injectable compounded options in one telehealth program.
Visit MEDVi
Ro
#20 of 36Best for users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.
Visit RoSide by side
MEDVi vs Ro at a glance
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | MEDVi | Ro |
|---|---|---|
| Why each one | A daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership. | The most trusted name in telehealth with the fastest prescription turnaround, same-day approval is standard, not the exception. |
| Our Score | 5.7/10 | 7.2/10 |
| Headline Price | $179 first month, then $299/mo | $149/mo membership + medication |
| Medication Type | Both | Brand |
| Insurance Accepted | No | Yes |
| Best For | Users who want both oral and injectable compounded options in one telehealth program | Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing |
| Watch out for | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication | Membership and medication are billed separately, readers need to add them together for the all-in monthly cost |
| Ranking | #25 | #20 |
| Get started | Visit MEDVi | Visit Ro |
Trade-offs
Strengths and cautions compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
- +Sleek onboarding experience with clear progress tracking through their patient portal
1 more documented strengths
- +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
- −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
2 more documented cautions
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Ro
Pros
- +Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149 to $299 a month depending on dose on its pricing page
- +Insurance support for the Wegovy pen, Zepbound autoinjector pen and Ozempic; coverage and copays are plan-dependent, with membership charged separately
- +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo prepaid annually, which its pricing page frames as a $900/year saving
1 more documented strengths
- +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx, some of the lowest cash brand prices available
Cons
- −Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
- −Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
- −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)
Our Verdict
Ro edges out MEDVi with a score of 7.2/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Ro is $149/mo membership + medication. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. MEDVi offers both brand-name and compounded medications, giving you more flexibility.
Keep narrowing the decision
What should you compare next?
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
- Pill decisionCompare Wegovy pill prices and accessUse the dedicated guide for dose-specific costs, required memberships and which providers currently list the FDA-approved pill.Continue
- Coverage decisionCheck your GLP-1 insurance pathLook up plan-specific coverage questions before treating a cash price or an insurance route as your final out-of-pocket cost.Continue
- Treatment decisionCompare semaglutide providers and pricesMove from this head-to-head to the broader semaglutide market without confusing compounded products with FDA-approved brands.Continue
Cheapest complete recurring price in our index
Eden Health GLP-1
$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both
Both MEDVi and Ro start above the cheapest complete recurring program we track. Across all 36 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving MEDVi and Ro.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare MEDVi and Maximuspublished $79.99/mo; total not verified
- Compare MEDVi and SkinnyRx$99 first month, renewal not verified
- Compare MEDVi and Luvo Healthfrom $249/4 weeks
- Compare Ro and Hers$188 first month, then $298/mo
- Compare Ro and Galafrom $149/mo
- Compare Ro and Oak Longevityfrom $167/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is MEDVi legit and is Ro legit, with the verification evidence behind each answer.
Our pick of these two: Ro · 7.2/10